| Sandoz Pharmaceuticals AG - Dasatinib Sandoz 50 mg, Filmtabletten | | 67368 | | 02 | | Dasatinib Sandoz 50 mg | | Filmtabletten | | L01EA02 | | Dasatinib | | 08.10.2020 | | |
| | Composition | | dasatinibum 50 mg, cellulosum microcristallinum, lactosum monohydricum 69 mg, carmellosum natricum conexum, hydroxypropylcellulosum, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, talcum, glyceroli monopalmitostearas, natrii laurilsulfas, pro compresso obducto corresp. natrium 1.456 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Dasatinib | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Dasatinib | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Glyceroli Monopalmitostearas | | | | Hydroxypropylcellulosum | | | | Lactose Monohydrate | 69 mg | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 60 | 1072.75 | 1183.10 | A | SL | Yes |
|
|
